The environment of increased concentration of docosahexaenoic acid in glioblastoma may suppress the anti-tumor effect of macrophages

Oncology Reports

Volumn 13, Issue 6, 2005, Pages 1185-1191

  Hirano, Hirofumi ^a   Takeshima, Hideo ^a   Niiro, Masaki ^a   Nagayama, Tetsuya ^a   Oyoshi, Tatsuki ^a   Kuratsu, Jun Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Docosahexaenoic acid; Glioblastoma; Macrophage; Necrosis

Indexed keywords

CHROMIUM; DOCOSAHEXAENOIC ACID;

APOPTOSIS; ARTICLE; BRAIN TUMOR; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; MACROPHAGE; METABOLISM; MONOCYTE; NECROSIS; PATHOLOGY; PHAGOCYTOSIS;

APOPTOSIS; BRAIN NEOPLASMS; CHROMIUM; DOCOSAHEXAENOIC ACIDS; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; MACROPHAGES; MONOCYTES; NECROSIS; PHAGOCYTOSIS;

EID: 24744463418     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.6.1185     Document Type: Article

References (35)

1. Desbaillets I, Tada M, de Tribolet N, Diserens AC, Hamou MF and Van Meir EG: Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer 58: 240-247, 1994. (Pubitemid 24240102)
2. Leung SY, Wong MP, Chung LP, Chan AS and Yuen ST: Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol 93: 518-527, 1997. (Pubitemid 27186993)
3. Nishie A, Ono M, Shono T, et al: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5: 1107-1113, 1999. (Pubitemid 29233226)
4. Hirano H, Tanioka K, Yokoyama S, Akiyama S and Kuratsu J: Angiogenic effect of thymidine phosphorylase on macrophages in glioblastoma multiforme. J Neurosurg 95: 89-95, 2001. (Pubitemid 32799777)
5. Cummings TJ, Hulette CM, Bigner SH, Riggins GJ and McLendon RE: Ham56-immunoreactive macrophages in untreated infiltrating gliomas. Arch Pathol Lab Med 125: 637-641, 2001. (Pubitemid 32429810)
6. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78, 2004.
7. Moore SA: Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci 16: 195-200, 2001.
8. Williard DE, Harmon SD, Kaduce TL, et al: Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J Lipid Res 42: 1368-1376, 2001. (Pubitemid 34007666)
9. Lee JY, Sohn KH, Rhee SH and Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276: 16683-16689, 2001.
10. Dustin LB, Shea CM, Soberman RJ and Lu CY: Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function. J Immunol 144: 4888-4897, 1990. (Pubitemid 20224132)
11. Tappia PS, Man WJ and Grimble RF: Influence of unsaturated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages. Mol Cell Biochem 143: 89-98, 1995.
12. Khair el Din TA, Sicher SC, Vazquez MA, Wright WJ and Lu CY: Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFN gamma-induced la-expression by murine macrophages in vitro. J Immunol 154: 1296-1306, 1995.
13. Khair el Din TA, Sicher SC, Vazquez MA and Lu CY: Inhibition of macrophage nitric-oxide production and Ia-expression by docosahexaenoic acid, a constituent of fetal and neonatal serum. Am J Reprod Immunol 36: 1-10, 1996. (Pubitemid 26276526)
14. Ohata T, Fukuda K, Takahashi M, Sugimura T and Wakabayashi K: Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by omega 3 polyunsaturated fatty.acids. Jpn J Cancer Res 88: 234-237, 1997. (Pubitemid 27170482)
15. Lu CY, Penfield JG, Khair el Din TA, et al: Docosahexaenoic acid, a constituent of fetal and neonatal serum, inhibits nitric oxide production by murine macrophages stimulated by IFN gamma plus LPS, or by IFN gamma plus Listeria monocytogenes. J Reprod Immunol 38: 31-53, 1998. (Pubitemid 28221411)
16. Khair El Din T, Sicher SC, Vazquez MA, et al: Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J Exp Med 183: 1241-1246, 1996. (Pubitemid 26113986)
17. Kielar ML, Jeyarajah DR, Penfield JG and Lu CY: Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NF kappa d response elements of the iNOS promoter. Transplantation 69: 2131-2137, 2000. (Pubitemid 30395049)
18. Jeyarajah DR, Kielar M, Penfield J and Lu CY: Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro. J Surg Res 83: 147-150, 1999. (Pubitemid 29391621)
19. Fyfe DJ and Abbey M: Effects of n-3 fatty acids on growth and survival of J774 macrophages. Prostaglandins Leukot Essent Fatty Acids 62: 201-207, 2000. (Pubitemid 30333210)
20. Takeshima H, Kuratsu J, Takeya M, Yoshimura T and Ushio Y: Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 80: 1056-1062, 1994. (Pubitemid 24154183)
21. Chen GG, Chu YS, Chak EC, Leung BC and Poon WS: Induction of apoptosis in glioma cells by molecules released from activated macrophages. J Neurooncol 57: 179-186, 2002. (Pubitemid 34692626)
22. Ohyama K: [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice], Nippon Geka Hokan 62: 92-115, 1993.
23. Zhang W, Arii S, Sasaoki T, et al: The role of Kupfler cells in the surveillance of tumor growth in the liver. J Surg Res 55: 140-146, 1993. (Pubitemid 23335789)
24. Nakabo Y and Pabst MJ: Lysis of leukemic cells by human macrophages: inhibition by 4-(2-aminoethyI)-benzenesulfonyl fluoride (AEBSF), a serine protease inhibitor. J Leukoc Biol 60: 328-336, 1996. (Pubitemid 26325614)
25. Morris CS and Esiri MM: Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 1. Gliomas. J Neurol Sci 101: 47-58, 1991.
26. Farquharson J, Cockburn F, Patrick WA, Jamieson EC and Logan RW: Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 340: 810-813, 1992.
27. Moore SA, Yoder E, Murphy S, Dutton GR and Spector AA: Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem 56: 518-524, 1991. (Pubitemid 21901992)
28. Martin DD, Robbins ME, Spector AA, Wen BC and Hussey DH: The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue. Lipids 31: 1283-1288, 1996. (Pubitemid 26425024)
29. Kaufmann AM, Cardoso ER and Bruni E: Method for preservation of water content during prolonged storage of cerebral tissue. Neurol Res 12: 57-59, 1990. (Pubitemid 20159767)
30. Kremer JM, Lawrence DA, Jubiz W, et al: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 33: 810-820, 1990. (Pubitemid 20205760)
31. Robinson DR, Xu LL, Tateno S, Guo M and Colvin RB: Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res 34: 1435-1444, 1993. (Pubitemid 23230320)
32. Fowler KH, Chapkin RS and McMurray DN: Effects of purified dietary n-3 ethyl esters on murine T lymphocyte function. J Immunol 151:5186-5197, 1993. (Pubitemid 23332328)
33. Jenski LJ, Scherer JM, Caldwell LD, Ney VA and Stillwell W: The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro. Lipids 33: 869-878, 1998. (Pubitemid 28460153)
34. McMurray DN, Jolly CA and Chapkin RS: Effects of dietary n-3 fatty acids on T cell activation and T cell receptor-mediated signaling in a murine model. J Infect Dis 182: 1s103-107, 2000.
35. Barker FG, 2nd, Davis RL, Chang SM and Prados MD: Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77: 1161-1166, 1996. (Pubitemid 26080909)s